BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Fuji
Cerilliant
Healthtrust
McKesson
Julphar
Citi
Baxter
Merck
Covington
QuintilesIMS

Generated: January 18, 2018

DrugPatentWatch Database Preview

DOLOBID Drug Profile

« Back to Dashboard

Which patents cover Dolobid, and what generic alternatives are available?

Dolobid is a drug marketed by Merck and is included in one NDA.

The generic ingredient in DOLOBID is diflunisal. There are seven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the diflunisal profile page.

US Patents and Regulatory Information for DOLOBID

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Merck DOLOBID diflunisal TABLET;ORAL 018445-001 Apr 19, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Merck DOLOBID diflunisal TABLET;ORAL 018445-002 Apr 19, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for DOLOBID

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck DOLOBID diflunisal TABLET;ORAL 018445-001 Apr 19, 1982 ➤ Subscribe ➤ Subscribe
Merck DOLOBID diflunisal TABLET;ORAL 018445-001 Apr 19, 1982 ➤ Subscribe ➤ Subscribe
Merck DOLOBID diflunisal TABLET;ORAL 018445-002 Apr 19, 1982 ➤ Subscribe ➤ Subscribe
Merck DOLOBID diflunisal TABLET;ORAL 018445-002 Apr 19, 1982 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Boehringer Ingelheim
Covington
Accenture
Cipla
Queensland Health
Chubb
AstraZeneca
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot